Fig. 1From: Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysisPatients who received both [18F]-F-PSMA-1007 and [68Ga]-Ga-PSMA-11 by indication and device. BCR: Biochemical recurrence; PS: primary staging; FU: follow-up of pre-known metastasesBack to article page